Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
Trial ID or NCT#
NCT02461420
Status
RECRUITING
Purpose
The purpose of this study is to comprehensively characterize PMS using standardized medical, cognitive, and behavioral measures and to track the natural history of the syndrome using repeated longitudinal assessments. In addition, this study will be aiming to identify biomarkers using neuroimaging, including diffusion tensor imaging and identify genetic factors which contribute to diverse phenotypes in patients with PMS.
Official Title
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
Eligibility Criteria
Ages Eligible for Study: Older than 18 Months
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
- - Individuals older than 18 months of age with pathogenic deletions or mutations of the SHANK3 gene - English speaking individuals
Exclusion Criteria:
- - Has taken an investigational drug as part of another research study, within 30 days prior to study enrollment - For subjects involved in imaging biomarker assessment: contraindications to 3T MRI scanning, such as metal implants/non-compatible medical devices or medical conditions, including vagus nerve stimulator - For subjects involved in EEG/ ERP biomarker assessment: contraindications to EEG/ERP, such as uncooperative or destructive behaviors preventing lead placement or capture by ERP/VEP equipment. Under age 2 or over age 11 at the time of enrollment. - Unwilling or unable to comply with study procedures and assessments
Investigator(s)
Jon Bernstein
Contact us to find out if this trial is right for you.
Contact
Julia Buckingham
650-725-0439
View on ClinicalTrials.gov
